Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Chubb
Harvard Business School
Fuji
Queensland Health
Accenture
Dow
Baxter

Generated: April 23, 2018

DrugPatentWatch Database Preview

TESTOSTERONE CYPIONATE Drug Profile

« Back to Dashboard

Which patents cover Testosterone Cypionate, and when can generic versions of Testosterone Cypionate launch?

Testosterone Cypionate is a drug marketed by Hikma Farmaceutica, Luitpold Pharms Inc, Mylan Institutional, Paddock Llc, Sandoz Inc, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, and West-ward Pharms Int. and is included in eleven NDAs.

The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
Drug patent expirations by year for TESTOSTERONE CYPIONATE
Pharmacology for TESTOSTERONE CYPIONATE
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Synonyms for TESTOSTERONE CYPIONATE
(17beta)-3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate
(1S,2R,10R,11S,14S,15S)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL 3-CYCLOPENTYLPROPANOATE
(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
053T944
17-(3-cyclopentyl-1-propionyl)-17beta-hydroxyandrost-4-en-3-one
17-(Cyclopentyl-1-oxopropoxy)androst-4-en-3-one, (17.beta.)-
17.beta.-Hydroxyandrost-4-en-3-one cyclopentylpropionate
17beta-Hydroxyandrost-4-en-3-one cyclopentylpropionate
3-Oxoandrost-4-en-17-yl 3-cyclopentylpropanoate, (17.beta.)- #
3-oxoandrost-4-en-17beta-yl 3-cyclopentylpropanoate
58-20-8
AB0090519
AB01274709-01
AB2000228
AC1L9B3P
AKOS007930349
AKOS015895326
Andro-Cyp
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17b)-
Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17beta)-
BRN 3174363
C-21939
C08156
CC-34816
CHEBI:9463
CHEMBL1201101
CT0176
D00957
Dep-Test
depAndro 100
depAndro 200
Depo-Testadiol
Depo-Testosterone
Depo-testosterone (TN)
Depo-testosterone cyclopentylpropionate
Depo-Testosterone cypionate
Depovirin
Durandro
EINECS 200-368-4
HPFVBGJFAYZEBE-ZLQWOROUSA-N
Jectatest
LMST02020074
M0XW1UBI14
Malogen CYP
MolPort-003-959-637
NSC 9157
Pertestis
PL000354
SCHEMBL40862
T-Ionate-P.A
Testodrin prolongatum
Testosterone 17-beta-cypionate
Testosterone 17.beta.-cyclopentanepropionate
Testosterone 17.beta.-cyclopentylpropionate
Testosterone 17.beta.-cypionate
Testosterone 17beta-cyclopentanepropionate
Testosterone 17beta-cyclopentylpropionate
Testosterone 17beta-cypionate
Testosterone cyclopentanepropionate
Testosterone cyclopentylpropionate
Testosterone cypionate (USP)
Testosterone cypionate [USP]
Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard
Testosterone, cyclopentanepropionate
Testosteronecypionate
UNII-M0XW1UBI14
W-105407
ZINC4097468

US Patents and Regulatory Information for TESTOSTERONE CYPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 091244-001 May 1, 2012 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 201720-001 Jun 3, 2013 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Paddock Llc TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 040530-001 Jan 31, 2005 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Pharms Inc TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 086030-001 Approved Prior to Jan 1, 1982 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Chinese Patent Office
Healthtrust
Merck
Accenture
Citi
Federal Trade Commission
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.